Therapeutically active pyrazolo-pyrimidine derivatives
USRE48622E1 · kind E1 · reissue
0Cited by
2References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 22, 2019 |
| Grant date | Jul 6, 2021 |
| Priority date | — |
| Expiry date | Jul 22, 2039 |
Classification
- Technology area (CPC —)General
Abstract
A series of pyrazolo[3,4-d]pyrimidine derivatives that are substituted at the 4-position by a diaza monocyclic, bridged bicyclic or spirocyclic moiety, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases and malaria; and organ and cell transplant rejection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.